Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol

Cancer Treat Rev. 1988 Jan:15 Suppl A:43-8. doi: 10.1016/0305-7372(88)90073-4.

Authors

F Mandelli¹, M Tribalto, G Avvisati, M Cantonetti, M T Petrucci, M Boccadoro, A Pileri, F Marmont, L Resegotti, V Lauta, et al.

Affiliation

¹ Department of Human Biopathology, University La Sapienza, Rome, Italy.

PMID: 3277709
DOI: 10.1016/0305-7372(88)90073-4

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Clinical Trials as Topic
Female
Humans
Interferon Type I / adverse effects
Interferon Type I / therapeutic use*
Male
Middle Aged
Multiple Myeloma / drug therapy
Multiple Myeloma / therapy*
Neoplasm Recurrence, Local / prevention & control
Random Allocation
Recombinant Proteins / therapeutic use*

Substances

Interferon Type I
Recombinant Proteins